All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for INDIVIOR INC. · pharmaceutical company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 20, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 1

Pharmacy

Issues related to overdose reversal products including Naloxone; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.